Borderline Hypertension by Julius, Stevo et al.
Acta Med Scand 208: 481489, 1980 
Borderline Hypertension 
Hypertension Seminars a t  Os tra  Hospi ta l ,  Giiteborg, Stt’eden 
Stevo Julius, Lennart  Hansson,  Lennart  Andren, Thorkell Gudbrandsson, 
Ramon Sivertsson and Anders Svensson 
From the Department of’ Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA,  
and the Hypertension Section. Departments of Medicine and Clinical Physiology, 
Ostra Hospital, University of Goteborg. Goteborg, Sweden 
ABSTRACT. Borderline hypertension was the topic 
of one of the “Hypertension seminars” arranged by 
the Hypertension Section at the Ostra Hospital, 
Goteborg, Sweden. On that occasion Professor Stevo 
Julius, Ann Arbor, Michigan, USA, was an invited 
guest. During the seminar, various aspects of border- 
line hypertension were discussed, e.g. the natural his- 
tory, hemodynamics and management of this condi- 
tion. The present review is based on these discus- 
sions. 
Key iivrds: borderline hypertension, hemodynamics, 
epidemiology. 
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It has  been shown beyond doubt ,  and there is gen- 
eral agreement today, that  arterial pressure in any  
population is distributed as a continuous variable, 
the curves  being Gaussian in shape when converted 
t o  the logarithmic scale. In other  words,  arterial 
pressure is a quantity,  not a quality. With this in 
mind, it is not logical t o  treat  arterial pressure as a 
quality and set  up  a dichotomy: normotension and 
hypertension, a fact repeatedly pointed ou t  by Sir  
George Pickering (75,  76) .  
The  fact  that  most physicians and scientists still 
use  the terms hypertension and normotension, and 
also the term borderline hypertension, the topic of 
this seminar,  does  not mean that they d o  not recog- 
nize that blood pressure (BP) is a quantitative vari- 
able.  T h e  use of  these terms reflects the realization 
that individuals with a certain level of  B P  have 
several common  physiologic and epidemiologic 
characteristics which often mandate  specific inves- 
tigative and practical approaches.  As will become 
evident during this seminar,  the term borderline 
hypertension signifies not just  a certain range of  B P  
between “normotension” and “hypertension”, but 
rather a clinical condition with recognizable and 
reproducible characteristics. 
D E F I N I T I O N S  
The WHO has defined hypertension as systolic BP (SBP) 
2 160 and/or diastolic BP (DBPp95 mmHg and normoten- 
sion as s 140/90 mmHg, leaving the range between these 
two delineations to be called borderline hypertension (101). 
The Ann Arbor group has previously defined patients with 
borderline hypertension as those having, out of five indi- 
rect casual BPs within the last year, at least one with a 
diastolic value a90 mmHg and at least one ~ 9 0  mmHg 
(45). Others have defined borderline hypertension as BP 
intermittently above 150 mmHg systolic or 90 mmHg dia- 
stolic (94). Since arterial pressure tends to increase with 
age in the Western world, all the above definitions have 
inherent problems, simply because they do not consider 
the age of the subject. However, the Ann Arbor group has 
recently taken age into consideration and defines border- 
line hypertension in the following manner: age 17-40: 
>140/90, <160/100; age 41-60: >150/90. <160/100 and 
age >60: > 160/90, < 175/100 (40). Obviously the intent of 
all these classifications is to delineate the mildest possible 
form of hypertension. Consequently, the term borderline 
hypertension excludes the existence of BP-related target 
organ damage such as hypertensive retinopathy and left 
ventricular hypertrophy (with conventional methods) or 
impaired renal function. 
A number of synonyms to borderline hypertension have 
been proposed. The term labile hypertension is not logical 
as it implies increased BP variability. Some of the early 
studies indicating a higher degree of BP variability in sub- 
jects with systolic blood pressure above 120 mmHg as 
compared to those with BPs below this level, are open to 
serious criticism, e.g. that in the lower BP group the 
upward variability of the BP was limited by definition (it 
could reach a maximum of 120 mmHg) whereas no such 
restrictions existed in the high BP group (78). 
Furthermore, several studies have demonstrated that 
there is no correlation between the level of BP and its 
variability when repeated measurements are made during 
1-3 weeks (10, 26). In addition, BP fluctuates markedly 
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even in normotensive individuals (4) .  I t  is therefore not 
surprising to find that an excessive variability of BP has 
never been established as a characteristic feature of bor- 
derline hypertension. Even if the BP variability were in- 
creased, the importance of this finding would be ques- 
tionable. The extreme ranges of BPdo not seem to predict 
the risk of cardiovascular disease. Thus, Sokolow et al. 
(85) found that the five highest and five lowest BPs during 
a 24-hour recording did not relate to cardiovascular mor- 
bidity, whereas the average BP during that period carried 
an important predictive power. The term "labile" should 
be reserved for individuals with extremely variable BPs, 
irrespective of whether these occur in the normotensive, 
borderline or hypertensive range. 
The term prehypertension indicates a condition which 
almost invariably leads to established hypertension. Since 
this is not the case, which will be shown later, the term is 
not logical. Latent hypertension points to a condition 
which may develop into hypertension or which may re- 
main latent, and this term is accordingly a useful 
synonym. Marginal hypertension is also acceptable. 
whereas early essential hypertension should be avoided 
for the same reasons as prehypertension. However, bor- 
derline hypertension is such an accepted and commonly 
used expression that any attempt to use synonyms for this 
condition is likely to cause confusion. For this reason we 
would recommend that the use of synonyms be restricted. 
EPIDEMIOLOGY 
The prevalence of borderline hypertension has been 
studied in several population surveys. In the Bergen 
study, performed in the 1950s. 8 %  of the males in 
the age group 20-30 years had borderline hyperten- 
sion and 13% in the 30-40 years group. The preval- 
ence of borderline hypertension was somewhat 
lower in women below 50 years of age, but with 
increasing age this difference disappeared (6) .  Also 
in the US the prevalence of borderline hypertension 
increases rapidly with increasing age (7). The prev- 
alence of borderline hypertension in university 
students in Michigan has been reported to be ap- 
proximately 20% (40). 
Accurate data about the prevalence of borderline 
hypertension in Sweden are lacking. However, if 
the prevalence data from the Alameda County BP 
study in California were valid also in Sweden. the 
total number of persons with borderline hyperten- 
sion would exceed one million (of a total population 
of 8 millions) (Table I ) .  
For a complete review of available data on the 
prevalence of borderline hypertension, see Julius 
and Schork (47). In this context it  should be 
stressed again that the definition of borderline hy- 
pertension, and indeed also of hypertension, be- 
comes crucial with advancing age. For example, a 
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Based on population data on Dec. 31.  1976. the total 
population of Sweden being 8236179 (90). and The 
Alameda County BP study (7)  





I9 900 1 600 
I I4 200 54 300 
163 100 I96 700 
106 800 351 400 
All 403 800 616 000 
All males and females 1 019 800 
population study of 70-year-old women in Goteborg 
indicated that no less than 48% had hypertension 
(92). demonstrating the dilemma of arbitrary de- 
finitions of hypertension. The incidence of border- 
line hypertension has repeatedly been found to be 
quite low. in the order of 1 %/year of observation 
(47, 5 2 ) .  
NATURAL HISTORY AND RISK FACTORS 
The later occurrence of established hypertension 
has repeatedly been found to be 2-5 times more 
common in individuals with borderline hyperten- 
sion than in those with initial normal BP. Still it 
should be stressed that only a minority of individu- 
als with borderline hypertension later develop es- 
tablished hypertension. An approximate figure for 
the accumulated overall risk is commonly con- 
sidered to be around 20% (44, 70, 73). 
The morbidity and mortality from cardiovascular 
disease in the population with borderline hyperten- 
sion is approximately twice as  high as  in a nor- 
motensive population (47). The increased morbidity 
in borderline hypertension shows a similar pattern 
to the morbidity observed in established hyperten- 
sion. Thus, an excess in myocardial infarction, 
strokes, congestive heart failure and ECG changes 
has been reported (32, 51. 57, 62, 88, 96). Con- 
sequently it is likely, but not proven, that this high- 
er morbidity occurs in the group (20%) of patients 
who will later develop established hypertension 
(hypertension-specific cardiovascular morbidity). 
A good example of morbidity in borderline hyper- 
tension can be found in the Framingham study, 
which showed a 50% increase in age-adjusted coro- 
nary heart disease (50, 51). Other studies have 
shown similar or  higher ( u p  to 200%) increases in 
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coronary morbidity in borderline hypertension (39, 
47, 57). The Framingham study also found an al- 
most doubled incidence of atherothrombotic brain 
infarct ion. 
The mortality in borderline hypertension is also 
increased. One could question the specificity of this 
mortality since in the report by Levy et al. (57), 
patients with borderline hypertension had a greater 
tendency to commit suicide. However, the Framing- 
ham study shows that the excess mortality in 
borderline hypertension is specific. 
A 50 o/o increased overall mortality for men and a 
75 5% increase for women with borderline hyperten- 
sion as compared to normotensive control groups 
was reported. The increase is largely due to car- 
diovascular mortality, which was twice the normal 
rate for men and four times that for women in age 
group 67-74 ( S O ) .  In younger age groups the in- 
crease in cardiovascular mortality was substantial 
but not as dramatic as in older ages (SO).  
As the risks for complications increase with rising 
BP (85), it is not surprising that a great deal of work 
and interest have gone into attempts to identify 
factors that predict future hypertension. As it hap- 
pens, the best predictor for future hypertension is 
high BP, i.e. the initial level is the strongest predic- 
tor for BP in the future ( I  I ,  32, 48, 64, 69, 87). 
Another, independent predictive factor is tachy- 
cardia, which is not a benign sign (70, 87). Levy et 
al. found that when both transient hypertension and 
transient tachycardia were present, the incidence of 
later established hypertension was more than twice 
the incidence when only one of these factors was 
present (58). 
Overweight is also associated with borderline and 
mild hypertension. High relative weight is a predic- 
tor of future hypertension, as is weight gain over a 
period of years (32, 37, 38, 70, 87, 89). 
A positive family history of hypertension is more 
common in patients with borderline BP elevation 
(42), and established hypertension occurs more of- 
ten in patients with a positive family history (29). 
The inheritance of arterial pressure is considered to 
be multigenetic but the exact mechanisms are not 
well known (80, 97). 
Interest has recently been focused on possible 
interactions between environmental and genetic- 
immunological factors in the development of hyper- 
tension (12, 93). The question has been asked 
whether there are genetic indicat0rs-e.g. certain 
HLA types-at least in some subpopulations in es- 
sential hypertension. If so, it might be possible to 
predict the prognosis or the risk for, e.g., vascular 
damage more reliably than is presently possible (27, 
53). However, to our knowledge no such studies 
have been performed systematically in individuals 
with borderline hypertension. 
In the overall US population the prevalence of 
borderline hypertension is very similar for black 
and white persons of both sexes, but established 
hypertension is twice as frequent in blacks, indicat- 
ing that race may be considered as a risk factor and 
that blacks carry a greater risk for progression from 
borderline to sustained hypertension (40). 
Using multiple logistic function to discern the 
quintile of the population with the highest risk of 
developing hypertension within 5 years, Stamler et 
al. (87) could identify at most 55% of all expected 
hypertensives in that quintile. 
A number of tests have been designed and 
employed in attempts to identify persons with an 
augmented risk of developing future hypertension, 
e.g. cold pressor test, salt loading, reaction to men- 
tal arithmetic, digital vascular reactivity to nor- 
adrenalin, apparent noradrenalin secretion test and 
tritiated noradrenalin test as well as different 
combinations of these. By and large such tests 
have proved to be of no predictive value, or al- 
ternatively they cannot be employed in practice or 
the needed long-term follow-up is still lacking (40, 
91). This holds true also for a new and most in- 
teresting approach: the abnormal Na+ and K +  net 
fluxes in erythrocytes of essential hypertensive pa- 
tients (also in relatives to hypertensive patients and 
in some women with hypertension during pregnan- 
cy) (25). Whether these abnormalities can really be 
used as markers for hypertension remains to be 
confirmed. 
HUMORAL FACTORS 
Catecholamine concentrations in urine or plasma 
are frequently used as indicators of sympathetic 
activity. It is, however, doubtful that patients with 
established hypertension have increased sympa- 
thetic activity as reflected by increased release of 
catecholamines (8, IS, 18, 19, 23, 34, 55,59,  68, 74, 
81). Age is of importance in this setting. since plas- 
ma concentration of noradrenalin is positively cor- 
related with age (23, 34, 74, 81). Activation of the 
cardiac sympathetic neurones increases urinary 
catecholamine excretion (9), whereas moderate 
activation of the peripheral sympathetic nervous 
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with hyperkinetic subgroup (Sivertsson et al.: Unpublished data). 
system does not increase plasma concentrations of 
adrenalin or  noradrenalin ( I ,  61). Some patients 
with established hypertension appear to have a true 
neurogenic hypertension and their BP can be nor- 
malized following total autonomic blockade ( 16). 
Hypertensive patients showing higher noradrenalin 
levels are usually young (23, 34, 81) and have also 
been reported to  have increased plasma renin ac- 
tivity (16). 
In comparison with normotensive individuals, 
borderline hypertensives usually have normal rest- 
ing plasma and urinary catecholamine concentra- 
tions (8, 67). Physical exercise induces elevation 
of both noradrenalin and adrenalin plasma concen- 
tration but patients with borderline hypertension d o  
not behave differently from normal controls in this 
respect. Patients with borderline hypertension 
have increased excretion of urinary catecholamines 
during mental stress (19, 67) and also an increased 
catecholamine response to  upright posture (19, 54). 
Poststress plasma catecholamines have recently 
been shown to be increased also in individuals with 
a genetic risk of developing hypertension as  well as  
in borderline hypertensives (20). 
As a group, borderline hypertensives have higher 
plasma renin activity than normotensive individuals 
and patients with established hypertension (24). Pa- 
tients with borderline hypertension have been sub- 
divided by their renin status (17) and approximately 
35% are in the ”high renin” group, 45% in the 
“normal renin” group and 20% in the “low renin” 
group (17). Patients with “hyperkinetic circulation” 
usually have high plasma renin activity (65). 
Total autonomic blockade with propranolol, at- 
ropine, and phentolamine normalizes the BP both in 
patients with high renin borderline hypertension 
and in high renin established, hypertension (16, 17). 
However, in patilents with normal or low renin 
hypertension the B P  remains elevated al$o follow- 
ing total autonomic blockade (l,7). This would seem 
to indicate that the high renin hypertensiues kave a 
neurogenic type of BP elevation. Obviously. the 
plasma renin activity per se does not induce the,BP 
elevation in these patients, since /3-adrenoceptor 
blockade with propranolol, which causes a marked 
decrease in plasma renin levels, does not reduce the 
elevated B P  (43). 
PERSONALITY TRAITS 
A few reports indicate that patients with border- 
line hypertension differ from normal controls in a 
number of psychological ways (28. 30). Thus, they 
are more submissive and have more suppressed 
hostility ( 2 8 ) .  They also more often exhibit distur- 
bances in sexual roles and have difficulties in in- 
teractions with other people (49). These aspects 
indicate that borderline hypertension could be re- 
garded as a psychosomatic disease. 
HEMODYNAMICS 
Ca rdicr c or( tprr t 
I t  is well documented that cardiac output at rest is 
increased in patients with borderline hypertension 
as  a group, in comparison with normotensive indi- 
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viduals (47). However, this does not mean that all 
individuals with borderline hypertension have an 
increased cardiac output. But in 30-5095 the cardiac 
output exceeds the value found in control subjects 
by 2 S . D .  or more. This difference between border- 
line hypertensives and normotensives seems to de- 
crease with increasing age (41, 60). Some studies 
indicate that the high output is caused by an ele- 
vated heart rate (24. 41. 60. 63, 79). others that it is 
due to an increased stroke volume (3 .  21) while still 
others have demonstrated that both factors are in- 
volved (13. 78. 100) (Table 11). 
The elevation of cardiac output is maintained by 
an increased sympathetic and a reduced vagal ac- 
tivity to the heart, which points to an altered central 
nervous activity in these individuals. Thus, cardiac 
output normalized after autonomic blockade with 
propranolol and atropine (45). Since the sensitivity 
of the /3-adrenoceptors in the myocardium is de- 
creased rather than increased in borderline hyper- 
tension. the high output state was not caused by 
local cardiac effects (43). 
Bloocl , .ol i i t?i i .  
Most studies show that blood volume or plasma 
volume is normal or slightly reduced in borderline 
hypertension (2, 21, 24, 63) while a few studies 
show significantly reduced values (22, 46, 78). Car- 
diopulmonary blood volume is probably normal in 
patients with borderline hypertension (78). In rela- 
tion to total blood volume, cardiopulmonary blood 
volume has been found to be normal (79) or in- 
creased (78). In  patients with hyperkinetic border- 
line hypertension, the cardiopulmonary blood vol- 
ume appears to be increased both in absolute and in 
relative terms (14). This centralization of blood from 
the periphery is probably a consequence of an in- 
creased vasomotor nerve tone on the capacitance 
vessels (78). Such a redistribution of the blood pool 
might influence stroke volume and cardiac output 
by increasing the venous return. Although there is a 
positive correlation between cardiac output and 
cardiopulmonary blood volume ( l4) ,  this does not 
prove a causal connectidn since vasomotor nerve 
activity may influence both these variables. On the 
contrary, some data indicate that the two factors 
are not causally related. Thus, autonomic nerve 
blockade normalizes cardiac output but not the cen- 
tral blood volume (14). A changed relation between 
central blood volume and stroke volume or cardiac 
index (increased stroke volume in relation to central 
blood volume) supports the idea that vasomotor 
nerve activity is the main determinant of the in- 
creased cardiac output in patients with borderline 
hypertension (14). 
Periplicrcrl ,~e.s.sel.s trnd ,wscrilcrr resistcinc'e 
At rest, total peripheral resistance in borderline 
hypertension is within normal limits, or in fact 
slightly reduced (Table 11). I t  has been pointed out, 
though, that in relation to cardiac output, vascular 
resistance is increased (46). The vascular resistance 
can be brought into the normal range by means of 
phentolamine in about 30% of patients with border- 
line hypertension (43). During intense physical 
exercise, total vascular resistance in borderline 
hypertension remains elevated (60, 79). Moreover, 
during infusion of dextran, the vascular resistance 
in borderline hypertension fails to adjust to the in- 
creased cardiac output (45). 
Adaptive structural changes in the resistance 
vessels seem to occur already in mild forms of 
hypertension (83, 84) (Table 11). This is in agree- 
ment with the echocardiographic observation of left 
ventricular hypertrophy in borderline hypertensive 
patients (56) .  A recent study has shown decreased 
venous distensibility in borderline hypertension 
(94). The claim was made that this decreased dis- 
tensibility was to a certain extent due to structural 
changes in the veins (94). However, the scientific 
support for this claim is not convincing and the 
findings may be explained by increased smooth 
muscle tone. 
MANAGEMENT 
I t  has been pointed out above that borderline hyper- 
tension constitutes an important risk factor for fu- 
ture cardiovascular complications. A logical con- 
sequence of this would be to lower the BP. However, 
available data so far, notably the Veterans Ad- 
ministration studies, have shown positive therapeu- 
tic effects as regards morbidity and mortality only 
in patients whose DBPs were 105 mmHg or higher 
(98,99). However, the HDFP (Hypertension Detec- 
tion and Follow-up Program) study (35, 36) de- 
monstrates for the first time a clear reduction in 
mortality also in patients whose DBPs were 90-105 
mmHg. Obviously, these important new results will 
have a profound effect on management policies for 
patients with mild hypertension. 
Before any kind of intervention is considered in 
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patients with borderline hypertension, it is obvious 
that the BP level should be determined with the 
greatest possible accuracy. Therefore, repeated 
measurements of BP with a reliable and standard- 
ized technique become mandatory. 
Borderline hypertensive patients are frequently 
overweight and since weight reduction lowers BP in 
obese hypertensive patients (33), it becomes ob- 
vious that reduction of body weight should be at- 
tempted in borderline patients, too. The BP-lower- 
ing effects of weight reduction have been shown to 
be independent of salt restriction (77). Still, salt 
reduction of a moderate degree will also lower BP. 
A reduction of daily salt intake from about 10 to 5 g 
may reduce the BP approximately lO/S mmHg (66, 
71). Dietary advice may also be beneficial in other 
ways, e.g. by correcting hyperlipidemia and glucose 
metabolism disturbances. 
In a review of non-pharmacological treatment 
of hypertension, Blackburn (5) pointed out that 
"Exercise can be recommended to mildly hyperten- 
sive patients, as to the entire public, for its long-term 
benefit in weight control in a sedentary society. 
However, it is not established that cardiovascular 
mechanisms involving autonomic nervous activity 
which are affected by high level conditioning exer- 
cise, have in fact, any independent or long-term 
antihypertensive effect." 
Behavioural methods to reduce high BP include 
biofeedback, relaxation, psychotherapy, environ- 
mental modification and placebo. In an extensive 
review of this field, Shapiro et al. (82) concluded 
that "widespread and uncritical application of be- 
havioural methods to the treatment of high blood 
pressure is premature". 
In the management of patients with hypertension, 
it is obvious that advice and information play im- 
portant roles. However, such information should be 
given with care. Canadian steel workers tended to 
have longer periods of non-attendance when aware 
of a hypertensive condition than controls who were 
not aware of having similar BP levels (31). 
In conclusion, non-pharmacological treatment 
and regular check-ups of BP constitute the basis for 
managing borderline hypertensive patients. Drug 
therapy is not recommended in cases of truly bor- 
derline hypertension, i.e. with DBPs sometimes be- 
low, sometimes slightly above 90 mmHg. However, 
the recent findings of the HDFP group clearly sup- 
port the opinion that pharmacological treatment 
should be instituted in hypertensive patients, even 
in the "mild range". i.e. with DBPs between 90 and 
105 mmHg (35. 36). Furthermore, treatment, par- 
ticularly with a P-adrenoceptor blocking agent, can 
be considered in borderline hypertensive patients 
with subjective symptoms related to their condi- 
tion, e.g. disturbing palpitations or tachycardia. 
I t  also stands to reason that treatment shall be 
attempted in those patients with borderline hyper- 
tension who are at high risk to develop future 
hypertension due to their family history, race, or 
uncorrectable other risk factors. Only moderate 
doses of drugs and only monotherapy are recom- 
mended in such cases. I t  would be unwise to apply 
the same aggressive stepped-care approach to 
treatment that is usually used in established hyper- 
tension. 
CONCLUSIONS 
Borderline hypertension refers to that gray zone 
between clearly normotensive and hypertensive BP 
values. I t  is interesting to note that a number of 
pathophysiological characteristics make it possible 
to separate borderline hypertension, on the one 
hand, from normotension and, on the other, from 
established hypertension. All the available data in- 
dicate that borderline hypertension constitutes the 
first phase in the development of established hyper- 
tension, although it should be pointed out that indi- 
viduals with BPs within the borderline range by no 
means are bound to develop established hyperten- 
sion. I t  is also worth noting that BPs within the 
borderline hypertensive range are associated with 
increased risks for cardiovascular morbidity and 
mortality. The newly published and clearly positive 
results of the HDFP study regarding antihyperten- 
sive therapy in mild hypertension will probably 
contribute to increased attention of this interesting 
clinical entity. 
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